[Associations of metabolic dysfunction-associated steatotic liver disease and cardiometabolic risk factor abnormalities with adverse pregnancy outcomes].
MASLD during pregnancy is associated with an increased risk of multiple adverse pregnancy outcomes, and the type and severity of CMRF abnormalities significantly influence this association. These results suggest that attention should be paid to the specific CMRF abnormalities when diagnosed MASLD, as this may help to facilitate targeted interventions and reduce the risk of adverse pregnancy outcomes.
Authors
- Hongjie Cui (ORCID: https://orcid.org/0000-0002-2152-8336)
- Yiqun Wu (ORCID: https://orcid.org/0000-0002-5554-1678)
- Y Wang (ORCID: https://orcid.org/0000-0001-9675-4840)
- Shuo Yang (ORCID: https://orcid.org/0000-0003-4164-4438)
- Yi Li (ORCID: https://orcid.org/0000-0002-5189-0627)
- Hui Wang (ORCID: https://orcid.org/0000-0002-7639-5702)
- Yu Yang (ORCID: https://orcid.org/0000-0002-5611-8951)
- Mengzhen Wang (ORCID: https://orcid.org/0000-0002-9473-3525)
- Yang Li (ORCID: https://orcid.org/0000-0002-6227-5160)
- N Enkar
Institutions
- Peking University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-06-18
- DOI
- https://doi.org/10.19723/j.issn.1671-167x.2025.03.012
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article